These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Antihypertensive mechanism of action and binding sites of nitrendipine. Triggle DJ Am J Cardiol; 1986 Sep; 58(8):35D-38D. PubMed ID: 2429539 [TBL] [Abstract][Full Text] [Related]
8. How do calcium antagonists differ in clinical practice? Ferrari R; Cucchini F; Bolognesi R; Bachetti T; Boraso A; Bernocchi P; Gaia G; Visioli O Cardiovasc Drugs Ther; 1994 Aug; 8 Suppl 3():565-75. PubMed ID: 7841090 [TBL] [Abstract][Full Text] [Related]
9. [Calcium antagonists. Great tissue selectivity is the basis of their therapeutic use]. Högestätt ED; Andersson KE Lakartidningen; 1997 Sep; 94(36):3024-6, 3029-31. PubMed ID: 9312623 [TBL] [Abstract][Full Text] [Related]
10. Class IV antiarrhythmic agents: new compounds using an old strategy. Szentandrássy N; Nagy D; Hegyi B; Magyar J; Bányász T; P Nánási P Curr Pharm Des; 2015; 21(8):977-1010. PubMed ID: 25354181 [TBL] [Abstract][Full Text] [Related]
11. [Calcium antagonists. Pharmacology and clinical pharmacology]. Grobecker H Med Monatsschr Pharm; 1994 May; 17(5):130-9. PubMed ID: 8022361 [No Abstract] [Full Text] [Related]
12. 1,4-Dihydropyridines as calcium channel ligands and privileged structures. Triggle DJ Cell Mol Neurobiol; 2003 Jun; 23(3):293-303. PubMed ID: 12825828 [TBL] [Abstract][Full Text] [Related]
13. From channels to cats: an overview of isradipine pharmacology. Rüegg UT; Hof RP Cor Vasa; 1990; 32(2 Suppl 1):12-22. PubMed ID: 2166635 [No Abstract] [Full Text] [Related]
14. Calcium channel antagonists in the treatment of coronary artery disease: fundamental pharmacological properties relevant to clinical use. Opie LH Prog Cardiovasc Dis; 1996; 38(4):273-90. PubMed ID: 8552787 [TBL] [Abstract][Full Text] [Related]
15. Pharmacologic and therapeutic differences among calcium channel antagonists: profile of mibefradil, a new calcium antagonist. Triggle DJ Am J Cardiol; 1996 Nov; 78(9A):7-12. PubMed ID: 8903279 [TBL] [Abstract][Full Text] [Related]
16. Calcium channel antagonists. What do the second-generation agents have to offer? Salerno SM; Zugibe FT Postgrad Med; 1994 Jan; 95(1):181-90. PubMed ID: 8278298 [TBL] [Abstract][Full Text] [Related]
17. Understanding the calcium channel blockers. Stone KS; Scordo KA Heart Lung; 1984 Sep; 13(5):563-73. PubMed ID: 6088433 [TBL] [Abstract][Full Text] [Related]